Trial Investigator Warned Over Lack of SOP Documentation

Clinical Trials Advisor
A A
A San Diego, Calif.-based clinical researcher received an FDA warning letter over its lack of documentation of standard operating procedures for overseeing studies and details of in-service protocol and specimen handling training in a Form 483 response.

To View This Article:

Login

Subscribe To Clinical Trials Advisor